REPORT ID 3818

EMEA (Europe, Middle East and Africa) OTC Drug Market Report 2017

Publish Date
14-Dec-17
Pages
113
Format
Electronic (PDF)

In this report, the EMEA OTC Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of OTC Drug for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA OTC Drug market competition by top manufacturers/players, with OTC Drug sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Bayer HealthCare
    GlaxoSmithKline (GSK)
    Johnson&Johnson
    Pfizer
    Sanofi
    AstraZeneca
    BioGaia
    Bristol Myers Squibb
    Bukwang Pharmaceutica
    Chr. Hansen
    Cipla
    CoLucid
    Daiichi Sankyo
    Friggs
    DSM
    Eisai
    Eli Lilly
    Herbalife
    Euradite

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Class A
    Class B

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital
    Clinic
    Household

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) OTC Drug Market Report 2017
1 OTC Drug Overview
    1.1 Product Overview and Scope of OTC Drug
    1.2 Classification of OTC Drug
        1.2.1 EMEA OTC Drug Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA OTC Drug Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Class A
        1.2.4 Class B
    1.3 EMEA OTC Drug Market by Application/End Users
        1.3.1 EMEA OTC Drug Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Household
    1.4 EMEA OTC Drug Market by Region
        1.4.1 EMEA OTC Drug Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of OTC Drug (2012-2022)
        1.5.1 EMEA OTC Drug Sales and Growth Rate (2012-2022)
        1.5.2 EMEA OTC Drug Revenue and Growth Rate (2012-2022)

2 EMEA OTC Drug Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA OTC Drug Market Competition by Players/Manufacturers
        2.1.1 EMEA OTC Drug Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA OTC Drug Revenue and Share by Players (2012-2017)
        2.1.3 EMEA OTC Drug Sale Price by Players (2012-2017)
    2.2 EMEA OTC Drug (Volume and Value) by Type/Product Category
        2.2.1 EMEA OTC Drug Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA OTC Drug Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA OTC Drug Sale Price by Type (2012-2017)
    2.3 EMEA OTC Drug (Volume) by Application
    2.4 EMEA OTC Drug (Volume and Value) by Region
        2.4.1 EMEA OTC Drug Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA OTC Drug Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA OTC Drug Sales Price by Region (2012-2017)

3 Europe OTC Drug (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe OTC Drug Sales and Value (2012-2017)
        3.1.1 Europe OTC Drug Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe OTC Drug Revenue and Growth Rate (2012-2017)
    3.2 Europe OTC Drug Sales and Market Share by Type
    3.3 Europe OTC Drug Sales and Market Share by Application
    3.4 Europe OTC Drug Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe OTC Drug Sales Volume by Countries (2012-2017)
        3.4.2 Europe OTC Drug Revenue by Countries (2012-2017)
        3.4.3 Germany OTC Drug Sales and Growth Rate (2012-2017)
        3.4.4 France OTC Drug Sales and Growth Rate (2012-2017)
        3.4.5 UK OTC Drug Sales and Growth Rate (2012-2017)
        3.4.6 Russia OTC Drug Sales and Growth Rate (2012-2017)
        3.4.7 Italy OTC Drug Sales and Growth Rate (2012-2017)
        3.4.8 Benelux OTC Drug Sales and Growth Rate (2012-2017)

4 Middle East OTC Drug (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East OTC Drug Sales and Value (2012-2017)
        4.1.1 Middle East OTC Drug Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East OTC Drug Revenue and Growth Rate (2012-2017)
    4.2 Middle East OTC Drug Sales and Market Share by Type
    4.3 Middle East OTC Drug Sales and Market Share by Application
    4.4 Middle East OTC Drug Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East OTC Drug Sales Volume by Countries (2012-2017)
        4.4.2 Middle East OTC Drug Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia OTC Drug Sales and Growth Rate (2012-2017)
        4.4.4 Israel OTC Drug Sales and Growth Rate (2012-2017)
        4.4.5 UAE OTC Drug Sales and Growth Rate (2012-2017)
        4.4.6 Iran OTC Drug Sales and Growth Rate (2012-2017)

5 Africa OTC Drug (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa OTC Drug Sales and Value (2012-2017)
        5.1.1 Africa OTC Drug Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa OTC Drug Revenue and Growth Rate (2012-2017)
    5.2 Africa OTC Drug Sales and Market Share by Type
    5.3 Africa OTC Drug Sales and Market Share by Application
    5.4 Africa OTC Drug Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa OTC Drug Sales Volume by Countries (2012-2017)
        5.4.2 Africa OTC Drug Revenue by Countries (2012-2017)
        5.4.3 South Africa OTC Drug Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria OTC Drug Sales and Growth Rate (2012-2017)
        5.4.5 Egypt OTC Drug Sales and Growth Rate (2012-2017)
        5.4.6 Algeria OTC Drug Sales and Growth Rate (2012-2017)

6 EMEA OTC Drug Manufacturers/Players Profiles and Sales Data
    6.1 Bayer HealthCare
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 OTC Drug Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Bayer HealthCare OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 GlaxoSmithKline (GSK)
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 OTC Drug Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 GlaxoSmithKline (GSK) OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Johnson&Johnson
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 OTC Drug Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Johnson&Johnson OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Pfizer
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 OTC Drug Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Pfizer OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Sanofi
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 OTC Drug Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Sanofi OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 AstraZeneca
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 OTC Drug Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 AstraZeneca OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 BioGaia
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 OTC Drug Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 BioGaia OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Bristol Myers Squibb
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 OTC Drug Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Bristol Myers Squibb OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Bukwang Pharmaceutica
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 OTC Drug Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Bukwang Pharmaceutica OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Chr. Hansen
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 OTC Drug Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Chr. Hansen OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Cipla
    6.12 CoLucid
    6.13 Daiichi Sankyo
    6.14 Friggs
    6.15 DSM
    6.16 Eisai
    6.17 Eli Lilly
    6.18 Herbalife
    6.19 Euradite

7 OTC Drug Manufacturing Cost Analysis
    7.1 OTC Drug Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of OTC Drug

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 OTC Drug Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of OTC Drug Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA OTC Drug Market Forecast (2017-2022)
    11.1 EMEA OTC Drug Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA OTC Drug Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA OTC Drug Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA OTC Drug Price and Trend Forecast (2017-2022)
    11.2 EMEA OTC Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe OTC Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt OTC Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa OTC Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA OTC Drug Sales Forecast by Type (2017-2022)
    11.7 EMEA OTC Drug Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer